However, the structure of the word suggests a few possible origins or interpretations:
In 2000, Genmab entered into a collaboration with GlaxoSmithKline (GSK) to develop a therapeutic antibody for the treatment of rheumatoid arthritis. This partnership led to the development of the antibody, known as HuMax-CD20, which was later approved by the US FDA under the brand name Ofatumumab (Arzerra) for the treatment of chronic lymphocytic leukemia (CLL). genemige
Possible intended terms could include:
A heavy boot kicked open the door. A Word-Knight stood there, his armor etched with the single, heavy word: OBEY. However, the structure of the word suggests a